Operaciones GoodRx Holdings, Inc. - GDRX CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.05 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024874% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.002651% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 5.99 |
Abrir* | 6.04 |
Cambio de 1 año* | -68.36% |
Rango del día* | 5.86 - 6.06 |
Rango de 52 semanas | 3.82-20.59 |
Volumen medio (10 días) | 1.58M |
Volumen medio (3 meses) | 36.08M |
Capitalización de mercado | 2.39B |
Ratio P/E | -100.00K |
Acciones en circulación | 397.57M |
Ingresos | 766.55M |
EPS | -0.08 |
Dividendo (Rendimiento %) | N/A |
Beta | -100.00K |
Próxima fecha de resultados | May 8, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 30, 2023 | 5.93 | -0.13 | -2.15% | 6.06 | 6.09 | 5.86 |
Mar 29, 2023 | 5.99 | 0.10 | 1.70% | 5.89 | 6.16 | 5.89 |
Mar 28, 2023 | 5.87 | -0.14 | -2.33% | 6.01 | 6.15 | 5.86 |
Mar 27, 2023 | 6.11 | -0.23 | -3.63% | 6.34 | 6.45 | 6.10 |
Mar 24, 2023 | 6.35 | -0.01 | -0.16% | 6.36 | 6.59 | 6.31 |
Mar 23, 2023 | 6.40 | -0.28 | -4.19% | 6.68 | 6.71 | 6.31 |
Mar 22, 2023 | 6.62 | 0.01 | 0.15% | 6.61 | 6.91 | 6.46 |
Mar 21, 2023 | 6.58 | 0.23 | 3.62% | 6.35 | 6.66 | 6.35 |
Mar 20, 2023 | 6.42 | 0.08 | 1.26% | 6.34 | 6.53 | 6.31 |
Mar 17, 2023 | 6.52 | 0.09 | 1.40% | 6.43 | 6.58 | 6.41 |
Mar 16, 2023 | 6.58 | 0.27 | 4.28% | 6.31 | 6.66 | 6.07 |
Mar 15, 2023 | 6.41 | 0.38 | 6.30% | 6.03 | 6.50 | 6.03 |
Mar 14, 2023 | 6.33 | 0.09 | 1.44% | 6.24 | 6.34 | 6.00 |
Mar 13, 2023 | 6.12 | 0.50 | 8.90% | 5.62 | 6.15 | 5.40 |
Mar 10, 2023 | 5.74 | 0.33 | 6.10% | 5.41 | 5.78 | 5.39 |
Mar 9, 2023 | 5.48 | 0.03 | 0.55% | 5.45 | 5.61 | 5.40 |
Mar 8, 2023 | 5.52 | 0.04 | 0.73% | 5.48 | 5.54 | 5.42 |
Mar 7, 2023 | 5.48 | -0.01 | -0.18% | 5.49 | 5.62 | 5.41 |
Mar 6, 2023 | 5.50 | -0.37 | -6.30% | 5.87 | 5.91 | 5.47 |
Mar 3, 2023 | 5.88 | 0.40 | 7.30% | 5.48 | 5.89 | 5.47 |
GoodRx Holdings, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 766.554 | 745.424 | 550.7 | 388.224 | 249.522 |
Ingresos | 766.554 | 745.424 | 550.7 | 388.224 | 249.522 |
Coste de los ingresos, total | 65.079 | 46.716 | 29.587 | 14.016 | 6.035 |
Beneficio bruto | 701.475 | 698.708 | 521.113 | 374.208 | 243.487 |
Gastos totales de explotación | 764.816 | 732.018 | 826.419 | 253.425 | 175.128 |
Gastos de venta/general/administración Gastos, total | 487.341 | 524.903 | 715.586 | 191.659 | 112.536 |
Investigación y desarrollo | 143.137 | 125.86 | 61.816 | 29.3 | 43.894 |
Depreciation / Amortization | 54.177 | 34.539 | 18.43 | 13.573 | 9.806 |
Ingresos de explotación | 1.738 | 13.406 | -275.719 | 134.799 | 74.394 |
Ingresos por intereses (gastos), netos No operativos | -24.969 | -23.583 | -27.753 | -48.854 | -22.039 |
Otros, netos | 0 | 0 | 0.022 | -2.967 | -0.007 |
Ingresos netos antes de impuestos | -23.231 | -10.177 | -303.45 | 82.978 | 52.348 |
Ingresos netos después de impuestos | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Beneficio neto antes de partidas extra. Elementos | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Ingresos netos | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Beneficio neto diluido | -32.828 | -25.254 | -293.623 | 66.048 | 43.793 |
Promedio ponderado de acciones diluidas | 412.858 | 409.981 | 274.696 | 383.223 | 383.223 |
BPA diluido sin partidas extraordinarias | -0.07951 | -0.0616 | -1.0689 | 0.17235 | 0.11428 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
BPA normalizado diluido | -0.04353 | -0.03893 | -1.06654 | 0.18248 | 0.12051 |
Gastos (ingresos) extraordinarios | 15.082 | 0 | 1 | 4.877 | 2.857 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Ingresos totales | 184.109 | 187.318 | 191.798 | 203.329 | 213.256 |
Ingresos | 184.109 | 187.318 | 191.798 | 203.329 | 213.256 |
Coste de los ingresos, total | 17.36 | 17.395 | 18.044 | 12.28 | 13.927 |
Beneficio bruto | 166.749 | 169.923 | 173.754 | 191.049 | 199.329 |
Gastos totales de explotación | 182.372 | 203.031 | 195.845 | 183.568 | 201.5 |
Gastos de venta/general/administración Gastos, total | 121.257 | 117.107 | 126.077 | 122.9 | 141.865 |
Investigación y desarrollo | 36.77 | 35.921 | 35.404 | 35.042 | 35.06 |
Depreciation / Amortization | 15.533 | 13.952 | 13.319 | 11.373 | 10.648 |
Ingresos de explotación | 1.737 | -15.713 | -4.047 | 19.761 | 11.756 |
Ingresos por intereses (gastos), netos No operativos | -6.482 | -6.558 | -6.112 | -5.817 | -5.886 |
Ingresos netos antes de impuestos | -4.745 | -22.271 | -10.159 | 13.944 | 5.87 |
Ingresos netos después de impuestos | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Beneficio neto antes de partidas extra. Elementos | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Ingresos netos | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Beneficio neto diluido | -1.972 | -41.734 | -1.415 | 12.293 | -39.914 |
Promedio ponderado de acciones diluidas | 411.67 | 412.956 | 412.135 | 427.378 | 414.068 |
BPA diluido sin partidas extraordinarias | -0.00479 | -0.10106 | -0.00343 | 0.02876 | -0.09639 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
BPA normalizado diluido | -0.02028 | -0.06244 | 0.00579 | 0.03348 | -0.08841 |
Otros, netos | 0 | ||||
Gastos (ingresos) extraordinarios | -8.548 | 18.656 | 3.001 | 1.973 | 0 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Activo Corriente | 1088.83 | 1086.37 | 86.582 | 73.071 | |
Efectivo e inversiones a corto plazo | 941.109 | 968.691 | 26.05 | 34.6 | |
Cash | 941.109 | 968.691 | 26.05 | 34.6 | |
Total deudores, neto | 126.411 | 97.293 | 48.129 | 35.023 | |
Accounts Receivable - Trade, Net | 118.08 | 68.729 | 48.129 | 33.359 | |
Prepaid Expenses | 21.307 | 17.484 | 12.403 | 3.448 | |
Total Assets | 1607.62 | 1470.11 | 386.796 | 314.791 | |
Property/Plant/Equipment, Total - Net | 49.317 | 50.769 | 34.175 | 0.988 | |
Property/Plant/Equipment, Total - Gross | 55.146 | 52.899 | 35.442 | 1.542 | |
Accumulated Depreciation, Total | -5.829 | -2.13 | -1.267 | -0.554 | |
Goodwill, Net | 329.696 | 261.116 | 236.225 | 220.42 | |
Intangibles, Net | 133.778 | 56.719 | 26.445 | 18.27 | |
Other Long Term Assets, Total | 6.007 | 15.142 | 3.369 | 2.042 | |
Total Current Liabilities | 81.113 | 59.551 | 33.373 | 16.62 | |
Accounts Payable | 17.501 | 10.291 | 7.851 | 7.2 | |
Accrued Expenses | 49.714 | 35.379 | 13.691 | 3.732 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 5.43 | |
Other Current Liabilities, Total | 6.869 | 6.852 | 4.802 | 0.258 | |
Total Liabilities | 775.945 | 758.755 | 737.369 | 740.209 | |
Total Long Term Debt | 655.858 | 659.888 | 663.893 | 716.806 | |
Long Term Debt | 655.858 | 659.888 | 663.893 | 716.806 | |
Deferred Income Tax | 0.244 | 3.456 | |||
Other Liabilities, Total | 38.73 | 39.316 | 40.103 | 3.327 | |
Total Equity | 831.68 | 711.359 | -350.573 | -425.418 | |
Redeemable Preferred Stock | 0 | 0 | 737.009 | 737.009 | |
Common Stock | 0.04 | 0.039 | 0.46 | 0.451 | |
Retained Earnings (Accumulated Deficit) | -1415.71 | -1390.45 | -1096.83 | -1162.88 | |
Total Liabilities & Shareholders’ Equity | 1607.62 | 1470.11 | 386.796 | 314.791 | |
Total Common Shares Outstanding | 398.681 | 391.66 | 383.223 | 383.223 | |
Additional Paid-In Capital | 2247.35 | 2101.77 | 8.788 | ||
Other Current Assets, Total | 0 | 2.9 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 994.723 | 1088.83 | 1051.54 | 1075.75 | 1123.38 |
Efectivo e inversiones a corto plazo | 845.427 | 941.109 | 912.023 | 894.703 | 990.463 |
Cash | 845.427 | 941.109 | 912.023 | 894.703 | 990.463 |
Total deudores, neto | 129.107 | 126.411 | 126.38 | 166.801 | 115.791 |
Accounts Receivable - Trade, Net | 123.281 | 118.08 | 98.511 | 87.004 | 74.399 |
Prepaid Expenses | 20.189 | 21.307 | 13.137 | 14.246 | 14.226 |
Other Current Assets, Total | 0 | 0 | 0 | 2.9 | |
Total Assets | 1538.33 | 1607.62 | 1614.36 | 1586.93 | 1510.97 |
Property/Plant/Equipment, Total - Net | 49.542 | 49.317 | 47.806 | 49.007 | 50.576 |
Goodwill, Net | 334.642 | 329.696 | 329.696 | 320.196 | 261.116 |
Intangibles, Net | 138.495 | 133.778 | 133.331 | 126.776 | 60.387 |
Other Long Term Assets, Total | 20.926 | 6.007 | 51.992 | 15.2 | 15.515 |
Total Current Liabilities | 59.364 | 81.113 | 72.681 | 65.491 | 63.049 |
Accounts Payable | 12.82 | 17.501 | 17.279 | 18.378 | 15.101 |
Accrued Expenses | 29.196 | 49.714 | 40.163 | 31.185 | 32.115 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 7.029 | 7.029 |
Other Current Liabilities, Total | 10.319 | 6.869 | 8.21 | 8.899 | 8.804 |
Total Liabilities | 751.821 | 775.945 | 767.969 | 762.535 | 761.915 |
Total Long Term Debt | 654.845 | 655.858 | 656.868 | 657.877 | 658.883 |
Long Term Debt | 654.845 | 655.858 | 656.868 | 657.877 | 658.883 |
Other Liabilities, Total | 37.215 | 38.73 | 38.42 | 39.167 | 39.983 |
Total Equity | 786.507 | 831.68 | 846.396 | 824.394 | 749.059 |
Common Stock | 0.04 | 0.04 | 0.039 | 0.039 | 0.039 |
Additional Paid-In Capital | 2189.88 | 2247.35 | 2222.15 | 2182.08 | 2137.8 |
Retained Earnings (Accumulated Deficit) | -1403.41 | -1415.71 | -1375.79 | -1357.72 | -1388.79 |
Total Liabilities & Shareholders’ Equity | 1538.33 | 1607.62 | 1614.36 | 1586.93 | 1510.97 |
Total Common Shares Outstanding | 396.132 | 398.681 | 398.681 | 395.393 | 392.457 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Deferred Income Tax | 0.397 | 0.244 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -25.254 | -293.623 | 66.048 | 43.793 | |
Efectivo de actividades de explotación | 178.779 | 131.341 | 83.286 | 45.253 | |
Efectivo de actividades de explotación | 34.539 | 18.43 | 13.573 | 9.806 | |
Deferred Taxes | 12.851 | -10.91 | -5.674 | -2.433 | |
Partidas no monetarias | 168.439 | 449.903 | 14.155 | 5.858 | |
Cash Taxes Paid | 18.105 | 29.228 | 19.4 | 11.7 | |
Intereses pagados en efectivo | 20.198 | 24.517 | 48.443 | 18.658 | |
Cambios en el capital circulante | -11.796 | -32.459 | -4.816 | -11.771 | |
Efectivo de actividades de inversión | -178.733 | -91.617 | -37.055 | -3.458 | |
Gastos de capital | -34.457 | -35.824 | -5.749 | -3.458 | |
Otras partidas de flujo de caja de inversión, total | -144.276 | -55.793 | -31.306 | 0 | |
Efectivo procedente de actividades de financiación | -30.528 | 905.817 | -54.781 | -24.734 | |
Elementos de flujo de caja de financiación | -58.52 | 15.043 | -2.214 | -1371.97 | |
Emisión (retiro) de acciones, neto | 35.021 | 897.803 | 4.665 | 740.358 | |
Emisión (amortización) de deuda, neta | -7.029 | -7.029 | -57.232 | 606.876 | |
Variación neta de la tesorería | -30.482 | 945.541 | -8.55 | 17.061 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 12.293 | -25.254 | 14.66 | 32.729 | 1.668 |
Cash From Operating Activities | 30.12 | 178.779 | 128.969 | 80.411 | 45.485 |
Cash From Operating Activities | 11.373 | 34.539 | 23.891 | 13.73 | 5.361 |
Deferred Taxes | -0.394 | 12.851 | -33.217 | -0.364 | -0.227 |
Non-Cash Items | 31.732 | 168.439 | 133.649 | 91.5 | 48.261 |
Changes in Working Capital | -24.884 | -11.796 | -10.014 | -57.184 | -9.578 |
Cash From Investing Activities | -34.401 | -178.733 | -169.474 | -142.416 | -9.695 |
Capital Expenditures | -12.418 | -34.457 | -25.198 | -16.688 | -9.695 |
Cash From Financing Activities | -91.401 | -30.528 | -19.063 | -14.883 | -14.018 |
Financing Cash Flow Items | -9.561 | -58.52 | -43.506 | -26.849 | -14.633 |
Issuance (Retirement) of Stock, Net | -80.082 | 35.021 | 29.715 | 15.481 | 2.372 |
Issuance (Retirement) of Debt, Net | -1.758 | -7.029 | -5.272 | -3.515 | -1.757 |
Net Change in Cash | -95.682 | -30.482 | -59.568 | -76.888 | 21.772 |
Other Investing Cash Flow Items, Total | -21.983 | -144.276 | -144.276 | -125.728 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.9222 | 8318305 | 503653 | 2023-02-28 | LOW |
Millennium Management LLC | Hedge Fund | 6.3441 | 5318603 | 3202061 | 2022-12-31 | HIGH |
Silver Lake Partners | Private Equity | 4.2134 | 3532276 | 0 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 3.9034 | 3272408 | -350301 | 2022-12-31 | HIGH |
Slutsky (Andrew) | Individual Investor | 3.8231 | 3205126 | 31512 | 2022-04-19 | LOW |
Two Sigma Investments, LP | Hedge Fund | 3.3532 | 2811137 | -168419 | 2022-12-31 | HIGH |
Perot Investments | Investment Advisor/Hedge Fund | 2.9135 | 2442504 | 278938 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.275 | 1907222 | -314400 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.196 | 1840994 | 137665 | 2022-12-31 | LOW |
Technology Crossover Ventures | Venture Capital | 1.9724 | 1653566 | 0 | 2022-12-31 | LOW |
Woodline Partners LP | Hedge Fund | 1.8145 | 1521212 | 1521212 | 2022-12-31 | HIGH |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.461 | 1224847 | -305486 | 2022-12-31 | MED |
Morgan Stanley & Co. LLC | Research Firm | 1.4091 | 1181280 | 39271 | 2022-12-31 | MED |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.043 | 874424 | -76919 | 2022-12-31 | MED |
Bezdek (Trevor) | Individual Investor | 0.967 | 810707 | 156900 | 2023-03-01 | LOW |
Hirsch (Douglas Joseph) | Individual Investor | 0.967 | 810707 | 156900 | 2023-03-01 | LOW |
BofA Global Research (US) | Research Firm | 0.9311 | 780570 | 157007 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9228 | 773657 | 270280 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8818 | 739278 | 51080 | 2022-12-31 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.87 | 729366 | -5662 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GoodRx Holdings, Inc. Company profile
Sobre Goodrx Holdings Inc
GoodRx Holdings, Inc. es una plataforma sanitaria digital centrada en el consumidor. La empresa ofrece la plataforma GoodRx, que agrega y analiza los datos de precios de una serie de fuentes diferentes. La plataforma proporciona acceso a programas de ahorro de medicamentos, consultas a proveedores médicos y pruebas de laboratorio a través de sus ofertas de telesalud, GoodRx Care y GoodRx Telehealth Marketplace, y otros contenidos relacionados con la atención sanitaria. Su oferta de prescripción proporciona comparaciones de precios y precios negociados en las prescripciones. Sus ofertas de suscripción proporcionan a los consumidores y a sus familias acceso a precios más bajos en medicamentos seleccionados en determinadas farmacias por una cuota de suscripción mensual o anual. Sus fabricantes de productos farmacéuticos ofrecen soluciones de asequibilidad, como tarjetas de copago, programas de asistencia al paciente, portales de atención y otras opciones de ahorro. Su oferta de transacciones de prescripción proporciona comparaciones de precios curadas y geográficamente relevantes y precios negociados en prescripciones
Industry: | Online Services (NEC) |
2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com